Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in
D

Decera Clinical EducationUnclaimed

Host of Decera Clinical Education Oncology Podcast.

Host, Decera Clinical Education Oncology Podcast

1PodCred credit

1 Feed-stated

Counts Verified and Feed-stated credits: what a show's own feed states, or a confirmation backs. See the record

  • Host

Claim this profile+ Add a creditIs this you? Claiming needs a free account. You sign in or join, then come straight back here.

This is not me · Request removal

+ FollowConnectMessageShare

This profile is unclaimed. PodSubs built it from public show feeds and credits. The person it is about has not reviewed it yet.

About this profile

Profile
Unclaimed
Shows now
1

About

Decera hosts Decera Clinical Education Oncology Podcast.

Written by PodSubs from Decera's credits.

PodCred record

PodCred is the verified record of where Decera has worked and appeared. These credits come from the shows' own feeds and wait for people who were there to confirm them.

Worked with Decera on a show? This is where you give them credit.

+ Add a credit

Shows they work on now

1 show

  • Decera Clinical Education Oncology Podcast
    Host Feed-stated

Is an appearance missing?

People get invited back because someone remembered they were great. If you heard this person on a show and it is not listed here, add it. Your memory might be the reason they get their next invitation.

No account needed. Anyone can give a credit.

Add an appearanceHow PodCred works

Experience, education, skills, and recommendations start empty. They fill in when Decera claims this profile.

Recommendations

ReceivedGiven

No recommendations for Decera yet.

Recommendations open once Decera claims the profile.

Recent episodes

From the shows they work on now

10 episodes
  • H3 K27M–Mutated Diffuse Midline Glioma: Bridging Molecular Pathology and Clinical Care

    Decera Clinical Education Oncology Podcast

    Nov 13, 202641 minAudio

    In this podcast episode, Craig Horbinski, MD, PhD, and Michael W. Ruff, MD, discuss the evolving diagnosis and management of H3 K27-altered diffuse midline glioma (DMG), emphasizing the importance of molecular testing,...

  • Hematologist On Call: Relapsed/Refractory Mantle Cell Lymphoma Post cBTKi

    Decera Clinical Education Oncology Podcast

    Nov 5, 202627 minAudio

    In this podcast episode, Toby A. Eyre, MD, MBChB, and Tycel J. Phillips, MD, FASCO, discuss the evolving treatment landscape of R/R mantle cell lymphoma as covalent BTK inhibitor use further expands into the first-line...

  • Rethinking MZL: From Established Options to T-Cell–Directed Therapies

    Decera Clinical Education Oncology Podcast

    Nov 4, 202630 minAudio

    This podcast explores the evolving treatment landscape for marginal zone lymphoma (MZL), focusing on individualized treatment selection, emerging cellular therapies, and novel T-cell-engaging approaches for...

  • TROP2-Directed ADCs in NSCLC: Current Evidence, Emerging Therapies, and Future Treatment Strategies

    Decera Clinical Education Oncology Podcast

    Oct 29, 202629 minAudio

    In this podcast episode, Christine M. Bestvina, MD, and Joshua E. Reuss, MD, discuss the current and emerging role of TROP2-directed ADCs in NSCLC, including: Current clinical use of Dato-DXd in previously treated...

  • Experts Discuss Key Topics in Treatment for Newly Diagnosed Multiple Myeloma

    Decera Clinical Education Oncology Podcast

    Oct 19, 202624 minAudio

    In this podcast episode, Jesus G. Berdeja, MD, and Ajai Chari, MD, discuss evolving therapy in newly diagnosed multiple myeloma, including: Selecting quadruplet therapy Optimal use of bortezomib The role of autologous...

  • PARP Inhibitors in Metastatic Prostate Cancer: Biomarker Testing, Treatment Strategies, and Toxicity Management

    Decera Clinical Education Oncology Podcast

    Oct 9, 202627 minAudio

    In this podcast episode, Neeraj Agarwal, MD, FASCO, and Emmanuel S. Antonarakis, MD, discuss the evolving role of PARP inhibitors in metastatic prostate cancer, emphasizing early molecular testing to identify...

  • Experts Discuss Sequencing of Therapies for Relapsed/Refractory Multiple Myeloma

    Decera Clinical Education Oncology Podcast

    Sep 30, 202629 minAudio

    Listen to Jesus G. Berdeja, MD, and Ajai Chari, MD, as they discuss sequencing of antibody-drug conjugates (ADCs), bispecific antibodies, CAR T-cell therapy, and other novel treatment modalities for patients with...

  • ASCO 2026 Updates in Metastatic Breast Cancer

    Decera Clinical Education Oncology Podcast

    Sep 22, 202619 minAudio

    In this podcast episode, Hope S. Rugo, MD, FASCO, and Nerea Lopetegui-Lia, MD, discuss practice-informing data presented at ASCO 2026 for patients with metastatic breast cancer, including: Findings from SERENA-6 on...

  • Evolving Role of B7-H3–Directed ADCs in the Extensive-Stage Small-Cell Lung Cancer Treatment Landscape

    Decera Clinical Education Oncology Podcast

    Sep 10, 202635 minAudio

    In this podcast episode, Charles Rudin, MD, PhD, and Mark A. Socinski, MD, discuss current gaps and clinical needs for patients with relapsed ES-SCLC, and the evolving role of B7-H3-directed antibody-drug conjugates in...

  • Targeting CDH6 in Platinum-Resistant Ovarian Cancer: Emerging ADCs, Biomarkers, and Sequencing

    Decera Clinical Education Oncology Podcast

    Sep 4, 202629 minAudio

    In this podcast episode, BJ Rimel, MD, and Elizabeth Lee, MD, discuss the scientific rationale for targeting CDH6 in ovarian cancer and the emerging role of CDH6-directed antibody-drug conjugates (ADCs) in...

Showing 5 of 10
Report this profile